Efficacy of Crohn’s disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart review

Abstract Background Recent trials suggested that the Crohn’s disease (CD) exclusion diet (CDED) plus partial enteral nutrition (PEN) is a safe and effective strategy in remission induction of paediatric-onset CD. However, real-world evidence regarding the safety and efficacy of the CDED plus PEN app...

Full description

Bibliographic Details
Main Authors: María Clara Jijón Andrade, Gemma Pujol Muncunill, Ana Lozano Ruf, Laura Álvarez Carnero, Victor Vila Miravet, Dolores García Arenas, Natalia Egea Castillo, Javier Martín de Carpi
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-023-02857-6
_version_ 1797789685412528128
author María Clara Jijón Andrade
Gemma Pujol Muncunill
Ana Lozano Ruf
Laura Álvarez Carnero
Victor Vila Miravet
Dolores García Arenas
Natalia Egea Castillo
Javier Martín de Carpi
author_facet María Clara Jijón Andrade
Gemma Pujol Muncunill
Ana Lozano Ruf
Laura Álvarez Carnero
Victor Vila Miravet
Dolores García Arenas
Natalia Egea Castillo
Javier Martín de Carpi
author_sort María Clara Jijón Andrade
collection DOAJ
description Abstract Background Recent trials suggested that the Crohn’s disease (CD) exclusion diet (CDED) plus partial enteral nutrition (PEN) is a safe and effective strategy in remission induction of paediatric-onset CD. However, real-world evidence regarding the safety and efficacy of the CDED plus PEN approach is still lacking. The present case-series study reported our experience with the outcomes of CDED plus PEN in the paediatric-onset CD at disease onset and after the loss of response to biologics. Methods We conducted a retrospective chart review on children who were treated with CDED plus PEN through the period from July 2019 and December 2020. Clinical and laboratory data were retrieved and compared at baseline, 6, 12, and 24 weeks of treatment. The primary endpoint of the present study was the rate of clinical remission. Results The present study retrieved the data from 15 patients. Of them, nine patients were treatment naïve at the time of initiation of CDED plus PEN (group A) and the remaining patients relapsed on biologics before treatment. All patients in groups A and B exhibited clinical remission in week six, which was sustained until week 12. At the end of the follow-up, the clinical remission rate was 87% and 60% in groups A and B, respectively. No side effects were observed in both groups. In group A, the faecal calprotectin (FC) and albumin improved at week six, week 12, and week 24 (p < 0.05). The erythrocyte sedimentation rate (ESR) improved significantly at week 12 (p = 0.021) and week 24 (p = 0.027). At the same time, the haemoglobin and iron levels showed significant improvement only at week 24. For group B, only FC showed numerical reductions over time that did not reach the level of statistical significance. Conclusion Treatment with CDED plus PEN was well tolerated and achieved an excellent clinical remission rate in treatment-naive patients. However, the benefit of CDED plus PEN was less in patients who initiated the strategy after losing the response to biologics.
first_indexed 2024-03-13T01:54:11Z
format Article
id doaj.art-21265cdd6f1b479d8c8bb3dfc3bbdb5d
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-03-13T01:54:11Z
publishDate 2023-06-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-21265cdd6f1b479d8c8bb3dfc3bbdb5d2023-07-02T11:17:39ZengBMCBMC Gastroenterology1471-230X2023-06-012311710.1186/s12876-023-02857-6Efficacy of Crohn’s disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart reviewMaría Clara Jijón Andrade0Gemma Pujol Muncunill1Ana Lozano Ruf2Laura Álvarez Carnero3Victor Vila Miravet4Dolores García Arenas5Natalia Egea Castillo6Javier Martín de Carpi7Unit for the Comprehensive Care of Paediatric IBD, Department of Paediatric Gastroenterology, Hepatology and Nutrition, Sant Joan de Déu HospitalUnit for the Comprehensive Care of Paediatric IBD, Department of Paediatric Gastroenterology, Hepatology and Nutrition, Sant Joan de Déu HospitalUnit for the Comprehensive Care of Paediatric IBD, Department of Paediatric Gastroenterology, Hepatology and Nutrition, Sant Joan de Déu HospitalUnit for the Comprehensive Care of Paediatric IBD, Department of Paediatric Gastroenterology, Hepatology and Nutrition, Sant Joan de Déu HospitalUnit for the Comprehensive Care of Paediatric IBD, Department of Paediatric Gastroenterology, Hepatology and Nutrition, Sant Joan de Déu HospitalUnit for the Comprehensive Care of Paediatric IBD, Department of Paediatric Gastroenterology, Hepatology and Nutrition, Sant Joan de Déu HospitalUnit for the Comprehensive Care of Paediatric IBD, Department of Paediatric Gastroenterology, Hepatology and Nutrition, Sant Joan de Déu HospitalUnit for the Comprehensive Care of Paediatric IBD, Department of Paediatric Gastroenterology, Hepatology and Nutrition, Sant Joan de Déu HospitalAbstract Background Recent trials suggested that the Crohn’s disease (CD) exclusion diet (CDED) plus partial enteral nutrition (PEN) is a safe and effective strategy in remission induction of paediatric-onset CD. However, real-world evidence regarding the safety and efficacy of the CDED plus PEN approach is still lacking. The present case-series study reported our experience with the outcomes of CDED plus PEN in the paediatric-onset CD at disease onset and after the loss of response to biologics. Methods We conducted a retrospective chart review on children who were treated with CDED plus PEN through the period from July 2019 and December 2020. Clinical and laboratory data were retrieved and compared at baseline, 6, 12, and 24 weeks of treatment. The primary endpoint of the present study was the rate of clinical remission. Results The present study retrieved the data from 15 patients. Of them, nine patients were treatment naïve at the time of initiation of CDED plus PEN (group A) and the remaining patients relapsed on biologics before treatment. All patients in groups A and B exhibited clinical remission in week six, which was sustained until week 12. At the end of the follow-up, the clinical remission rate was 87% and 60% in groups A and B, respectively. No side effects were observed in both groups. In group A, the faecal calprotectin (FC) and albumin improved at week six, week 12, and week 24 (p < 0.05). The erythrocyte sedimentation rate (ESR) improved significantly at week 12 (p = 0.021) and week 24 (p = 0.027). At the same time, the haemoglobin and iron levels showed significant improvement only at week 24. For group B, only FC showed numerical reductions over time that did not reach the level of statistical significance. Conclusion Treatment with CDED plus PEN was well tolerated and achieved an excellent clinical remission rate in treatment-naive patients. However, the benefit of CDED plus PEN was less in patients who initiated the strategy after losing the response to biologics.https://doi.org/10.1186/s12876-023-02857-6Crohn’s diseaseCrohn’s disease exclusion dietPartial enteral nutritionRemissionPaediatrics
spellingShingle María Clara Jijón Andrade
Gemma Pujol Muncunill
Ana Lozano Ruf
Laura Álvarez Carnero
Victor Vila Miravet
Dolores García Arenas
Natalia Egea Castillo
Javier Martín de Carpi
Efficacy of Crohn’s disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart review
BMC Gastroenterology
Crohn’s disease
Crohn’s disease exclusion diet
Partial enteral nutrition
Remission
Paediatrics
title Efficacy of Crohn’s disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart review
title_full Efficacy of Crohn’s disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart review
title_fullStr Efficacy of Crohn’s disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart review
title_full_unstemmed Efficacy of Crohn’s disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart review
title_short Efficacy of Crohn’s disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart review
title_sort efficacy of crohn s disease exclusion diet in treatment naive children and children progressed on biological therapy a retrospective chart review
topic Crohn’s disease
Crohn’s disease exclusion diet
Partial enteral nutrition
Remission
Paediatrics
url https://doi.org/10.1186/s12876-023-02857-6
work_keys_str_mv AT mariaclarajijonandrade efficacyofcrohnsdiseaseexclusiondietintreatmentnaivechildrenandchildrenprogressedonbiologicaltherapyaretrospectivechartreview
AT gemmapujolmuncunill efficacyofcrohnsdiseaseexclusiondietintreatmentnaivechildrenandchildrenprogressedonbiologicaltherapyaretrospectivechartreview
AT analozanoruf efficacyofcrohnsdiseaseexclusiondietintreatmentnaivechildrenandchildrenprogressedonbiologicaltherapyaretrospectivechartreview
AT lauraalvarezcarnero efficacyofcrohnsdiseaseexclusiondietintreatmentnaivechildrenandchildrenprogressedonbiologicaltherapyaretrospectivechartreview
AT victorvilamiravet efficacyofcrohnsdiseaseexclusiondietintreatmentnaivechildrenandchildrenprogressedonbiologicaltherapyaretrospectivechartreview
AT doloresgarciaarenas efficacyofcrohnsdiseaseexclusiondietintreatmentnaivechildrenandchildrenprogressedonbiologicaltherapyaretrospectivechartreview
AT nataliaegeacastillo efficacyofcrohnsdiseaseexclusiondietintreatmentnaivechildrenandchildrenprogressedonbiologicaltherapyaretrospectivechartreview
AT javiermartindecarpi efficacyofcrohnsdiseaseexclusiondietintreatmentnaivechildrenandchildrenprogressedonbiologicaltherapyaretrospectivechartreview